Omalizumab: anaphylactic shock: sometimes occurs more than one hour after the injection.
Sometimes occurs more than one hour after the injection.
D000707:Anaphylaxis / Q000139:chemically induced*; D000888:Antibodies, Anti-Idiotypic / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D005060:Europe; D006801:Humans; D014481:United States
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal